TY - JOUR
T1 - Age influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-host disease of varying severity following allogeneic hematopoietic cell transplant
AU - Nakane, Takahiko
AU - Fukuda, Takahiro
AU - Kanda, Junya
AU - Taniguchi, Shuichi
AU - Eto, Tetsuya
AU - Ohashi, Kazuteru
AU - Nakamae, Hirohisa
AU - Kurokawa, Mineo
AU - Mori, Takehiko
AU - Morishima, Yasuo
AU - Nagamura-Inoue, Tokiko
AU - Sakamaki, Hisashi
AU - Atsuta, Yoshiko
AU - Murata, Makoto
N1 - Publisher Copyright:
© 2015 © 2015 Informa UK, Ltd.
PY - 2015/8/3
Y1 - 2015/8/3
N2 - We retrospectively analyzed 2682 patients who developed grade II-IV acute graft-versus-host disease (GVHD). On analysis with stratification into five age groups (20-29, 30-39, 40-49, 50-59 and ≥ 60), 2-year non-relapse mortality rates (NRM) after the onset of GVHD were 20.7, 26.2, 26.6, 37.0 and 40.4%, respectively (p < 0.001). We found a significant interaction between the patient's age and GVHD severity with respect to NRM (p = 0.004). On multivariate analyses stratified by GVHD severity, the hazard ratio (HR) for NRM in the groups aged 50 years or more (reference: age group 20-29) was about twice as great in patients with grade II acute GVHD when compared with grade III-IV disease (HR in those aged 50-59 years: 2.9 for grade II and 1.5 [p = 0.03 and 0.04] for grades III-IV; HR if ≥ 60 years: 3.3 for grade II and 1.5 for grades III-IV [p < 0.001 for both]).
AB - We retrospectively analyzed 2682 patients who developed grade II-IV acute graft-versus-host disease (GVHD). On analysis with stratification into five age groups (20-29, 30-39, 40-49, 50-59 and ≥ 60), 2-year non-relapse mortality rates (NRM) after the onset of GVHD were 20.7, 26.2, 26.6, 37.0 and 40.4%, respectively (p < 0.001). We found a significant interaction between the patient's age and GVHD severity with respect to NRM (p = 0.004). On multivariate analyses stratified by GVHD severity, the hazard ratio (HR) for NRM in the groups aged 50 years or more (reference: age group 20-29) was about twice as great in patients with grade II acute GVHD when compared with grade III-IV disease (HR in those aged 50-59 years: 2.9 for grade II and 1.5 [p = 0.03 and 0.04] for grades III-IV; HR if ≥ 60 years: 3.3 for grade II and 1.5 for grades III-IV [p < 0.001 for both]).
KW - Clinical results
KW - graft-versus-host disease
KW - transplant toxicity
UR - http://www.scopus.com/inward/record.url?scp=84943389885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84943389885&partnerID=8YFLogxK
U2 - 10.3109/10428194.2015.1009056
DO - 10.3109/10428194.2015.1009056
M3 - Article
C2 - 25629984
AN - SCOPUS:84943389885
SN - 1042-8194
VL - 56
SP - 2392
EP - 2397
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - 8
ER -